chlorure de sodium aguettant 0.9 % inf. sol. i.v.
laboratoire aguettant - sodium chloride 9 g/1000 ml - solution for infusion - sodium chloride
chlorure de sodium aguettant 0.9 % inf. sol. i.v.
laboratoire aguettant - sodium chloride 9 g/1000 ml - solution for infusion - sodium chloride
chlorure de sodium aguettant 0.9 % inf. sol. i.v.
laboratoire aguettant - sodium chloride 9 g/1000 ml - solution for infusion - sodium chloride
chlorure de sodium aguettant 0.9 % inf. sol. i.v.
laboratoire aguettant - sodium chloride 9 g/1000 ml - solution for infusion - sodium chloride
chlorure de sodium aguettant 0.9 % inf. sol. i.v.
laboratoire aguettant - sodium chloride 9 g/1000 ml - solution for infusion - sodium chloride
chlorure de sodium aguettant 0.9 % inf. sol. i.v.
laboratoire aguettant - sodium chloride 9 g/1000 ml - solution for infusion - sodium chloride
chlorure de sodium aguettant 0.9 % inf. sol. i.v.
laboratoire aguettant - sodium chloride 9 g/1000 ml - solution for infusion - sodium chloride
chlorure de sodium aguettant 0.9 % inf. sol. i.v.
laboratoire aguettant - sodium chloride 9 g/1000 ml - solution for infusion - sodium chloride
chlorure de sodium aguettant 0.9 % inf. sol. i.v.
laboratoire aguettant - sodium chloride 9 g/1000 ml - solution for infusion - sodium chloride
sodium iodide (i-131) 200mbq/ml therapy solution oral liquid bp vial
australian nuclear science and technology organisation t/a ansto - sodium iodide(131i), quantity: 50 mbq - oral liquid, solution - excipient ingredients: sodium thiosulfate pentahydrate; water for injections; sodium bicarbonate - sodium iodide (131i) solution bp (for therapy) is indicated in the treatment of hyperthyroidism's and the detection and ablation of residual functioning thyroid tissue in differentiated thyroid carcinoma